Company Data
Rallybio Corporation
Ticker
RLYB
Current Price
$0.313824 -1.62%
Market Cap
$13.1M
Price Target
Refer to Report
Volume
27.2K
52wk Range
$0.2201 - $1.7291
Overview
Rallybio Corp is a biopharmaceutical company committed to identifying and accelerating the development of life-transforming therapies for patients with severe and rare disorders. Its lead program is for the prevention of fetal and neonatal alloimmune thrombocytopenia, a potentially life-threatening rare disease that can cause uncontrolled bleeding in fetuses and newborns.